Podcasts about molecular

In de podcastserie Proefschriften spreekt aios interne geneeskunde dr. Tessa Steenbruggen met promovendi. In deze speciale aflevering spreekt zij met dr. Paul Hengeveld over zijn proefschrift, getiteld: ‘Molecular risk stratification in chronic lymphocytic leukemia'. Paul vertelt hoe moleculaire risicostratificatie kan helpen in voorspellen van de prognose van patiënten met chronische lymfatische leukemie (CLL) en filosofeert over de toekomst van MRD (measurable residual disease) bij CLL. Paul heeft 27 maart 2024 zijn proefschrift succesvol verdedigd aan de Erasmus Universiteit bij prof. dr. Ton Langerak en co-promotoren dr. Mark-David Levin en dr. Peter Westerweel. Hij kreeg dit jaar tijdens de hematologiedagen het Jaap Steenbergen Stipendium voor het beste hematologieproefschrift van 2024.Referenties Inspiratietip: Belgische televisieserie - Met gevoel voor tumor Prognose CLL – THEMIS2 MRD CLL10 Sequentiële MRD HOVON-139 FLAIR-studie

El catedrático de Bioquímica y Biología Molecular en la Universidad de Oviedo Carlos López-Otín es entrevistado por Ramón González Férriz en una nueva sesión de Memorias de la Fundación, cuyos protagonistas son destacadas personalidades provenientes de diferentes ámbitos de la cultura que fueron destinatarios de becas o ayudas de la Fundación Juan March. Fue merecedor de una beca de investigación de la Fundación Juan March en 1988 con la que presentó la memoria titulada Microsecuenciación de proteínas: aplicación al estudio de proteínas implicadas en demencia senil y enfermedades relacionadas. Es miembro de la Academia Europea y de la Real Academia de Ciencias de España. Ha publicado más de trescientos artículos en prestigiosas revistas internacionales, y también desarrolla una destacada labor como ensayista, con libros como La vida en cuatro letras, El sueño del tiempo, con Guido Kroemer, y Egoístas, inmortales y viajeras. Su título más reciente es La levedad de las libélulas (2024).Más información de este acto

Welcome to the podcast with Dr. Brendan McCarthy!   In this episode we dive deep into one of the most misunderstood and debated topics in hormone health: testosterone replacement therapy (TRT) for women. You may have heard horror stories—or glowing reviews. But what's the truth? Dr. McCarthy discusses: - Why testosterone matters for women's health - How it affects brain chemistry, mood, bone density, and even breast tissue - Its role after estrogen-suppressing breast cancer treatments - The difference between safe and unsafe TRT - What your provider should be doing to monitor and manage it effectively   Dr. Brendan McCarthy founded Protea Medical Center in 2002. While he's been the chief medical officer, Protea has grown and evolved into a dynamic medical center serving the Valley and Central Arizona. A nationally recognized as an expert in hormone replacement therapy, Dr McCarthy s the only instructor in the nation who teaches BioHRT on live patients. Physicians travel to Arizona to take his course and integrate it into their own practices. Besides hormone replacement therapy, Dr. McCarthy has spoken nationally and locally before physicians on topics such as weight loss, infertility, nutritional therapy and more.   Citations: Popma, Arne, et al. "Cortisol moderates the relationship between testosterone and aggression in delinquent male adolescents." Biological psychiatry 61.3 (2007): 405-411 Likhtik, E., Stujenske, J. M., Topiwala, M. A., Harris, A. Z. & Gordon, J. A. Prefrontal entrainment of amygdala activity signals safety in learned fear and innate anxiety. Nat. Neurosci. 17, 106–113 (2014). Brannon, Skylar M., et al. "Exogenous testosterone increases sensitivity to moral norms in moral dilemma judgements." Nature Human Behaviour 3.8 (2019): 856-866.. * M.H.M. Hutschemaekers, R.A. de Kleine, M.L. Davis, M. Kampman, J.A.J. Smits, K. Roelofs,Endogenous testosterone levels are predictive of symptom reduction with exposure therapy in social anxiety disorder,Psychoneuroendocrinology,Volume 115,2020,104612 Barel, E, Abu‐Shkara, R, Colodner, R, et al. Gonadal hormones modulate the HPA‐axis and the SNS in response to psychosocial stress. J Neuro Res. 2018; 96: 1388– 1397. https://doi.org/10.1002/jnr.24259 * Buades-Rotger, M., Engelke, C., Beyer, F. et al. Endogenous testosterone is associated with lower amygdala reactivity to angry faces and reduced aggressive behavior in healthy young women. Sci Rep 6, 38538 (2016). https://doi.org/10.1038/srep38538 Ando, Sebastiano, et al. "Breast cancer: from estrogen to androgen receptor." Molecular and cellular endocrinology193.1-2 (2002): 121-128. Somboonporn, Woraluk, and Susan R. Davis. "Testosterone effects on the breast: implications for testosterone therapy for women." Endocrine reviews 25.3 (2004): 374-388. Donovitz, Gary, and Mandy Cotten. "Breast cancer incidence reduction in women treated with subcutaneous testosterone: testosterone therapy and breast cancer incidence study." European journal of breast health 17.2 (2021): 150. Glaser, Rebecca L., Anne E. York, and Constantine Dimitrakakis. "Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study." BMC cancer 19.1 (2019): 1271.   Thank you for tuning in and don't forget to hit that SUBSCRIBE button! Let us know in the COMMENTS if you have any questions or what you may want Dr. McCarthy to talk about next!   Check out Dr. Brendan McCarthy's Book! https://www.amazon.com/Jump-Off-Mood-...   -More Links- Instagram: www.instagram.com/drbrendanmccarthy TikTok: www.tiktok.com/drbrendanmccarthy Clinic Website: www.protealife.com

Drs. Jensen and Richey welcome Dr. Nicole Brouyette to Dean's Chat! Dr. Brouyette currently serves as the Associate Program director for Henry Ford Health System Residency program in Detroit MI. She got her undergraduate degree at Wayne State University with a Bachelors of Science in Molecular biology. She completed her Doctorate of Podiatric Medicine with the Ohio College and completed her 3 yr surgical residency training program with St. Johns Hospital and Medical center in Detroit MI. Join us as we discuss “all things podiatric medicine and surgery!”  This episode is sponsored by Bako Diagnostics! Dr. Brouyette is a true leader in the profession. Tune in for our discussion about her role as Associate program director and the overall structure and flow of the Henry Ford Health System Residency program. She also leans in and shares her experiences starting the Paragon28 Women in Podiatric Surgery Summit. Dr. Brouyette discusses the importance of female mentorship and some of the barriers young women face in medicine as they try to juggle the various roles they wish to pursue. She speaks openly and honestly about the challenges of being a woman in healthcare and how sometimes our own expectations can add additional stress in our lives. The discussion is uplifting, vulnerable and authentic as we discuss residency training, motherhood, maternity leave, feeling the need to fit into group and the power and freedom of living an authentic life.   Her career has been built on excellence. She has served in numersou leadership roles including ACFAS Great Lakes region Vice President, Member of the ACFAS Education and Scientific affairs committee, and faculty for AO NOrth America. She serves as section editor for the Journal of Foot and Ankle Surgery, NBPME Joint review panel for practitioners Part1 and has published a myriad of journal articles, poster presentations and invited lectures to various educational symposiums. We hope you enjoy this episode!    https://bmef.org/  https://paragon28meded.com/weekend-dpm-2024/vital-voices-womens-summit  https://www.abfas.org/residents  https://www.acfas.org/  https://www.aofoundation.org/aona     

En este capítulo, revisamos las diferentes estrategias para optimizar el soporte respiratorio en recién nacidos. En este episodio nos acompañan las neonatólogas Ana Ruth Mejia Elizondo y Victoria Lima Rogel. La Dra. Ana Ruth Mejia Elizondo es egresada de la Universidad Autónoma de San Luis Potosí donde obtuvo su título médico y posteriormente su posgrado en pediatría y neonatología. Actualmente es médico adscrito y jefe de servicio de Neonatología en el Hospital Central Dr. Ignacio Morones Prieto además de ser profesora de postgrado de pediatría y neonatología en la Universidad Autónoma de San Luis Potosí. La Dra. Victoria Lima Rogel es egresada de la Universidad Autónoma de San Luis Potosí. Posteriormente se especializó en Pediatría y Neonatología en la Universidad Nacional Autónoma de México. Cursó una Maestría en Ciencias en Biología Molecular en el Instituto Potosino de Investigación Científica y Tecnológica A.C. Actualmente es médico adscrito en el Hospital Central Dr. Ignacio Morones Prieto. Tiene una amplia currícula, tanto en instituciones del servicio público, como en la medicina privada, así como en campos de la ciencia y la investigación médica.Este podcast es patrocinado por Fisher & Paykel Healthcare. Bienvenidos a La Incubadora: una conversación sobre neonatología y medicina basada en evidencia. Nuestros episodios ofrecen la dosis ideal (en mg/kg) de los más recientes avances para el neonato y para las increíbles personas que forman parte de la medicina neonatal. Soy tu host, Maria Flores Cordova, MD. Este podcast está presentado por los médicos neonatólogos Dani de Luis Rosell, Elena Itriago, Carolina Michel y Juliana Castellanos. No dudes en enviarnos preguntas, comentarios o sugerencias a nuestro correo electrónico: nicupodcast@gmail.comSíguenos en nuestras redes:Twitter: @incubadorapodInstagram: @laincubadorapodcast Creado originalmente por Ben Courchia MD y Daphna Yasova Barbeau MD http://www.the-incubator.org

Dana Foss and Ross Wilson are the cofounders of Editpep, a biotech startup focused on developing CRISPR-based therapeutics. They are using a proprietary peptide-based delivery platform that enables targeted delivery to specific cell types, particularly for hard-to-reach areas like the brain. While Dana Foss is the CEO, Ross Wilson is also an Assistant Adjunct Professor of Molecular and Cell Biology and also the Director of Therapeutic Delivery at the Innovative Genomics Institute at the University of California, Berkeley. He is one of those very few academics that co-founded a startup and is very active in building Editpep. Ross explains how he does it all so well! Dana was  previously a postdoc in Ross Wilson's lab, where she developed the technology. Ross was a postdoc in Nobel Laureate Jennifer Doudna's lab. Now he has his own lab and collaborates with Jennifer Doudna at the Innovative Genomics Institute.  In this episode of lab to startup, we will explore their initial decisions that lead to launching the startup; existing CRISPR delivery technologies, their challenges, and then do a deep dive into their delivery technology. opportunities,; fundraising efforts, and their future goals. Shownotes https://www.editpep.bio/ CRISPR Delivery problem and current solutions Existing solutions like AV, LNPs are mostly limited to mice Ribonucleoprotein, a complex of RNA and protein (RNP): Technology deep dive Outsiders bringing in fresh perspective Dana transitioning out of academia: working on a shared goal Hard to shepard the technology towards the patient by depending on a third party Self motivation and gumption: Ways to move technologies out of the lab Early stage co-founder chemistry Ross's innovative role being an academic and entrepreneur Fundraising journey Open mindedness to non-traditional investors Investors: Berkeley Skydeck,  Lindonlight Collective Filters for selecting investors Getting to market: Parallels from other delivery companies like Alnylam Counterintuitive decisions Future goals Connecting the dots

Cystic Fibrosis and obesity?  Until recently this has not been a topic of conversation for the CF community. The reason for obesity in the CF community is better health and longer lives, so the concern is now a reality.  University of Michigan CF doctor, Carey Lumeng is researching the issue.  As he says in this podcast, researchers have a lot to learn about the connection between better health in CF and obesity.  We also talk about The Bonnell Foundation fellowship program. A few years ago we started the program to encourage doctors to work in the specialty field of cystic fibrosis. Dr. Lumeng is one of the doctors who oversees this program.Dr. Lumeng is the Frederick G.L. Huetwell Professor for the Cure and Prevention of Birth Defects and Professor in Pediatrics and Molecular and Integrative Physiology. Dr. Lumeng is the Division Chief of Pediatric Pulmonology at the C.S. Mott Children's Hospital and Associate Director of the Michigan MSTP Program.He grew up in Indiana and graduated from Princeton University in Molecular Biology. He received his PhD in Human Genetics and MD from the University of Michigan and completed residency training in Pediatrics in the Boston Combined Pediatrics Residency Program at Boston Children's Hospital and Boston Medical Center. He then completed fellowship training in Pediatric Pulmonology at the University of Michigan and started as faculty in 2006.  He runs a research lab focused on the health effects of obesity and the links between metabolism and lung health. The laboratory participates in both basic science and translational research projects in adult and pediatric obesity. He is funded by the NIH and the CF Foundation for new projects studying the changing causes of diabetes in people with CF.To contact the CF pediatric department (the Bonnell girls are pictured on this page): https://www.mottchildren.org/conditions-treatments/cystic-fibrosis-pediatric?pk_vid=6ff46bd2d38fe04c1739891353f5b28b Please like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredThanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/en

Garrett Butler, MD. Husband, father, son, friend, and family doc in rural WV. Undergraduate in Physics from Johns Hopkins University. Undergraduate in Molecular and Cell Biology from Towson University. MD from West Virginia University School of Medicine. Family Medicine residency at WVU SOM. Hospitalist at Vandalia Health Davis Medical Center. Outpatient family physician at Vandalia Health Broaddus Family Care. Hospitalist at Vandalia Health Broaddus Hospital. Medical director of Mansfield Place nursing home. Work With Us: Arétē by RAPID Health Optimization Links: Dr. Garrett Butler - Old Fellow Manor Anders Varner on Instagram Doug Larson on Instagram Coach Travis Mash on Instagram

Nelver - Proud Eagle Radio Show #572 [Pirate Station Online] (14-05-2025) ✅ Subscribe to Telegram channel: https://t.me/nelvermusic All episodes: https://band.link/proudeagle YouTube Video: https://youtu.be/Yzy-2LfSNWM Tracklist: 01. Feed The Fire - Circles 02. Toronto Is Broken - SOMEWHEREIBELONG (feat. REEBZ & Sebotage) 03. streetflicker - Don't Wanna 04. KNGHT - Time 05. Voicians - Lost 06. Teni - Money (goddard. Remix) 07. James Hiraeth & Grace Barton - See Me Now 08. Feint - Flicker 09. Erio & Rokschoon - Walk The Line 10. Degs & Hologram & 4K - Pressure 11. Grafix & Nu-La - Vital Signs 12. coil circuit - Range 13. Lukher - Clockwork 14. Alphas Wear Grey - Make it Smooth 15. Silloh - Dungeons 16. Telm & Wilson - Will-O-Wisp 17. Re:growth - Close To Me 18. Kursiva - Lost It 19. Dizrupt & MKJAY - Reap 20. Molecular - Got Game 21. Baboon - Confusion 22. Minor Forms - Used To It 23. ZeroZero - You Tell Me 24. Workforce - Overnight Express [feat. SP:MC] (Break Remix) 25. Nelver & Duoscience - Return 26. Molecular & Klinical - Know That 27. Melinki - Radical Sound 28. Dub Elements & MIDNIGHT CVLT & Coppa - Keep The Energy Up 29. Albees - 1990 30. Acris - Unseen Forces 31. Alfs & Merdz - Siren 32. Afex - Moment 33. Nelver - Search Within 34. Exposure - Searching 35. N.O.C.K - Infinite 36. Nymfo & Rider Shafique - Dark Sun 37. Kipsy - Walk In The Park 38. Nelver - Away 39. Nelver & Alpha Rhythm - Raindrops 40. Revan & Satl - Warble Music 41. Jrace & Albert White - Hold On (Erice Remix) 42. Nelver - Someone Else 43. Furney - Swanko 44. Aleyum & Philth & Lance - Hooked 45. Nelver - What You Are 46. Dephzac - Sunshine 47. Nelver - Just Me 48. A.P.O.L.L.O - Far Away 49. HK Sage - The Farewell Letter 50. Nelver - Our Time 51. Nelver & Aperio - Constellations 52. Science of Man - Fools (Dont lose it) 53. CRSV - Hopes & Dreams 54. Nelver - Silence 55. Wez Walker - Pass The Blame 56. Zero T & Onj & Minor Forms - No Way 57. Nelver - Time Forward Weekly updated Playlist "Proud Eagle" on Spotify: https://spoti.fi/2W5vkVa Follow Nelver: https://www.instagram.com/nelvermusic/ https://vk.com/nelver https://spoti.fi/2ThGKDT https://soundcloud.com/nelver https://www.facebook.com/nelverdnb/ https://www.mixcloud.com/Nelver/ https://twitter.com/Nelvermusic #nelvermusic #drumandbass #newmusic #electronicmusic #dnbculture #vibes #mood #exclusive #trending #viral #proudeagle

Increasing demand for surface water r and recycled water for irrigation has led to H2O, with high salt concentrations being used for crops.

A gente cresce ouvindo que ter filho é algo natural. Que basta querer — e pronto, acontece. Mas quem já passou pela jornada de tentar engravidar sabe que, muitas vezes, a realidade é bem mais complexa. Hoje, o Brasil tem uma taxa de fecundidade de apenas 1,57 filhos por mulher — a mais baixa da nossa história, bem abaixo do nível de reposição populacional. E isso não é só escolha: também é contexto. Mais mulheres estão deixando pra engravidar depois dos 30. Só que o corpo nem sempre acompanha esse novo tempo. A idade média da mulher ao ter o primeiro filho já passou dos 30 anos nas grandes capitais. E, ao mesmo tempo, cerca de 8 milhões de brasileiros enfrentam algum tipo de infertilidade. E aqui começa a via sacra: o peso da decisão, os exames, os custos, as tentativas frustradas. A gente fala em liberdade reprodutiva, mas essa liberdade ainda é muito restrita. Porque escolher ter um filho, adiar ou não ter envolve custo emocional, financeiro, físico — e quase sempre, é a mulher quem arca com tudo isso. Hoje, o Mamilos abre espaço pra falar com honestidade sobre a experiência de ser tentante. Sobre o corpo, a cabeça e o coração. Então puxa o banquinho, vem com a gente! Participam com a gente: Natália Gonçalves: Doutora em Biologia Celular e Molecular pela USP e head de Reprodução Humana da Dasa. Aline Borges de Araújo: Psicóloga especialista em Psicologia Clínica e Psicossomática, com foco em infertilidade e maternidade, ex-responsável pelo atendimento psicológico em Reprodução Humana da Unifesp. Anuncie no Mamilos ou contrate a consultoria Milos: mamilos@mamilos.me Saiba mais em Mamilos.me

This episode features Dan exploring the molecular mechanics of stretching and explaining the biological effects that occur when we lengthen our tissues. Stretching receives a lot of incorrect information and poor representation on social media platforms where sensationalised messages overshadow true scientific knowledge. This episode establishes accurate knowledge by explaining human body structure and function using biomechanics beginning with molecular components and extending to larger systems.Dan starts with an explanation of body organisation levels from molecular through systemic structures before examining how collagen, elastin and other proteins construct the extracellular matrix and provide connective tissue with strength and flexibility. The study of these molecules helps explain the behaviour of tissues during stretching and adaptation.This episode confronts multiple enduring myths that self-proclaimed "instagurus" have circulated. The episode examines common myths by analysing claims which state "stretching kills tissues" and "stretching is only neural." Dan uses biomechanics and molecular biology principles to evaluate these statements while teaching listeners critical thinking skills for online information.At the conclusion of this episode you'll gain an improved understanding of stretching mechanisms at the cellular and molecular levels and the necessity of this knowledge for practical biomechanical applications.

Anina Zürcher spoke with Mark Bartold, the first author of our key publication, "Molecular and cell biology of the gingiva." With over 420 citations, this paper has made a significant impact on the field of oral regeneration.  In the interview, Bartold explains the roles of different cells—like fibroblasts, immune cells, and epithelial cells—in tissue health, inflammation, healing, and periodontal regeneration. He also highlights the difference between regeneration and reconstruction and why understanding the tissues and molecular pathways involved is key to achieving predictable outcomes.

Discussing:Association between risk-reducing surgeries and survival in young BRCA carriers with #BreastCancer DESTINY-Breast11 Update from IndustryPALMIRA in Breast #Cancer (Palbo rechallenge)PEACE V STORM in #Prostate CancerMAGNITUDE :Niraparib and Abiraterone Acetate plus Prednisone in Met CR Prostate CancerOS EGFR-mutant AdvancedNon-Small Cell #LungCancer Treated with 1L Osimertinib Cemiplimab monotherapy as 1L treatment of patients with brain metastases from advanced #NSCLC with  PDL1 ≥50%Beyond fluorodeoxyglucose: Molecular imaging of cancer in precision medicine and more

The asteroid Vesta may be a fragment of a much larger protoplanet, and astronomers examine old data to discover a large molecular cloud lurking right in the solar system's backyard. Get all the details, plus habitable exoplanets get another look, space news, and trivial matters with your friendly neighborhood astroquarks.

Sponsor Details:Insta360 X5 Camera. To bag a free invisible selfie stick worth US$24.99 with your purchase, head to store.insta360.com and use the promo code "spacetime", available for the first 30 standard package purchases only.This episode of SpaceTime explores fascinating new discoveries and urgent updates from the cosmos.First, astronomers have identified a vast molecular gas and dust cloud named Eos, located just 300 light years away from Earth. This remarkable finding, published in the journal Nature Astronomy, marks the first detection of a molecular cloud using far ultraviolet emissions of molecular hydrogen. Eos, which is composed primarily of hydrogen, presents unique opportunities for studying the interstellar medium and the processes of star formation. We discuss the implications of this discovery and how it could reshape our understanding of molecular clouds across the galaxy.Jupiter's Polar Cyclones Under the MicroscopeNext, we delve into the latest revelations from NASA's Juno mission, which is providing new insights into Jupiter's ferocious polar cyclones and the volcanic activity on its moon Io. With fresh observations, scientists are uncovering the dynamics of Jupiter's atmosphere and the subsurface temperature profile of Io, shedding light on the gas giant's extreme weather patterns and the moon's geological activity.Out of Control Russian SpacecraftFinally, we discuss the impending re-entry of the Venera 8 spacecraft, a remnant of the Soviet era, which is expected to crash back to Earth on May 10. Launched in 1972, this spacecraft has been tumbling in low Earth orbit for over five decades. We examine the risks associated with its uncontrolled descent and the potential impact it may have upon re-entry.www.spacetimewithstuartgary.com✍️ Episode ReferencesNature Astronomyhttps://www.nature.com/natureastronomy/NASA Juno Missionhttps://www.nasa.gov/mission_pages/juno/main/index.htmlBecome a supporter of this podcast: https://www.spreaker.com/podcast/spacetime-space-astronomy--2458531/support.00:00 This is space Time Series 28, episode 54 for broadcast on the 5th May, 202500:48 Astronomers have discovered a vast invisible molecular, gas and dust cloud near Earth12:40 Two key experiments are needed to help us understand the origin of Jupiter15:42 A failed Soviet spacecraft designed to land on Venus is about to crash on Earth19:00 New study claims people who use cannabis have higher risk of heart attack21:12 New study claims ghost lanterns in South Carolina may be caused by earthquakes

Video: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://mehlmanmedical.com/hy-usmle-q-1364-molecular-bio⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠IG: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/mehlman_medical/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Telegram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://mehlmanmedical.com/subscribe/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠FB: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/mehlmanmedical⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

En este episodio nos acompañan las neonatólogas Ana Ruth Mejia Elizondo y Victoria Lima Rogel. La Dra. Ana Ruth Mejia Elizondo es egresada de la Universidad Autónoma de San Luis Potosí donde obtuvo su título médico y posteriormente su posgrado en pediatría y neonatología. Actualmente es médico adscrito y jefe de servicio de Neonatología en el Hospital Central Dr. Ignacio Morones Prieto además de ser profesora de postgrado de pediatría y neonatología en la Universidad Autónoma de San Luis Potosí. La Dra. Victoria Lima Rogel es egresada de la Universidad Autónoma de San Luis Potosí. Posteriormente se especializó en Pediatría y Neonatología en la Universidad Nacional Autónoma de México. Cursó una Maestría en Ciencias en Biología Molecular en el Instituto Potosino de Investigación Científica y Tecnológica A.C. Actualmente es médico adscrito en el Hospital Central Dr. Ignacio Morones Prieto. Tiene una amplia currícula, tanto en instituciones del servicio público, como en la medicina privada, así como en campos de la ciencia y la investigación médica.Este podcast es patrocinado por Fisher & Paykel Healthcare. Bienvenidos a La Incubadora: una conversación sobre neonatología y medicina basada en evidencia. Nuestros episodios ofrecen la dosis ideal (en mg/kg) de los más recientes avances para el neonato y para las increíbles personas que forman parte de la medicina neonatal. Soy tu host, Maria Flores Cordova, MD. Este podcast está presentado por los médicos neonatólogos Dani de Luis Rosell, Elena Itriago, Carolina Michel y Juliana Castellanos. No dudes en enviarnos preguntas, comentarios o sugerencias a nuestro correo electrónico: nicupodcast@gmail.comSíguenos en nuestras redes:Twitter: @incubadorapodInstagram: @laincubadorapodcast Creado originalmente por Ben Courchia MD y Daphna Yasova Barbeau MD http://www.the-incubator.org

In this week's episode, we'll hear about how researchers look toward the lung, and find uniquely programmed blood stem cells. This study is the first to fully characterize hematopoietic stem and progenitor cells in the adult human lung. After that: researchers develop a neural network-based probabilistic classifier, DLBclass, that assigns all diffuse large B-cell lymphomas into one of five genetic subtypes. It's an inclusive taxonomy that they say provides actionable genetic information in almost all patients with DLBCL. Finally, new insights on NETS, or neutrophil extracellular traps. In the liver vasculature, NET removal leads to secondary inflammation, resulting in new waves of NETS that may impact future infection. We'll review these and other findings from this recent mouse model study.Featured Articles:Decoding functional hematopoietic progenitor cells in the adult human lungDLBclass: a probabilistic molecular classifier to guide clinical investigation and practice in diffuse large B-cell lymphomaDonor regulatory T-cell therapy to prevent graft-versus-host disease

In this episode, you'll hear about the latest developments in tailoring cancer treatments to individual patients using Precision Oncology.  Two thought leaders, Simone Ndujiuba, a Clinical Oncology Pharmacist at Prime Therapeutics, and Karan Cushman, Head of Brand Experience and host of The Precision Medicine Podcast for Trapelo Health, discuss real-world research that is paving the way for Prime and our partners to help providers reduce turnaround times so patients can start treatment as soon as possible.  Join your host Maryam Tabatabai as they dig into this evolving topic of precision oncology. www.primetherapeuitics.com ⁠Chapters⁠Defining precision medicine (08:50)Evaluating real-world operational process of biomarker testing (14:36)Turnaround times are crucial (17:40)A patients view into the importance of time (24:39)Technology and process aid in time and process (29:30)Helping bridge knowledge gaps for providers and payers (33:55) The focus is on Precision Oncology right now (37:00)Precision medicine in other disease categories (40:09)Future of precision oncology is bright (42:07) References Singh, B.P., et al. (2019). Molecular profiling (MP) for malignancies: Knowledge gaps and variable practice patterns among United States oncologists (Onc). American Society of Clinical Oncology. https://meetings. asco.org/abstracts-presentations/173392 Evangelist, M.C., et al. (2023). Contemporary biomarker testing rates in both early and advanced NSCLC: Results from the MYLUNG pragmatic study. Journal of Clinical Oncology, 41(Supplement 16). https://doi.org/10.1200/JCO.2023.41.16_suppl.9109. Ossowski, S., et al. (2022). Improving time to molecular testing results in patients with newly diagnosed, metastatic non-small cell lung cancer. Journal of Clinical Oncology, 18(11). https://doi.org/10.1200/OP.22.00260 Naithani N, Atal AT, Tilak TVSVGK, et al. Precision medicine: Uses and challenges. Med J Armed Forces India. 2021 Jul;77(3):258-265. doi: 10.1016/j.mjafi.2021.06.020.  Jørgensen JT. Twenty Years with Personalized Medicine: Past, Present, and Future of Individualized Pharmacotherapy. Oncologist. 2019 Jul;24(7):e432-e440. doi: 10.1634/theoncologist.2019-0054.  MedlinePlus. What is genetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/genetics/understanding/testing/genetictesting/. MedlinePlus. What is pharmacogenetic testing? Retrieved on April 21, 2025 from https://medlineplus.gov/lab-tests/pharmacogenetic-tests/#:~:text=Pharmacogenetics%20(also%20called%20pharmacogenomics)%20is,your%20height%20and%20eye%20color.  Riely GJ, Wood DE, Aisner DL, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: non-small cell lung cancer, V3.2005. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.  Benson AB, Venook AP, Adam M, et al. National Cancer Comprehensive Network (NCCN) clinical practice guidelines: colon cancer, V3.2025. Retrieved April 21, 2025 from https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf. Rosenberg PS, Miranda-Filho A. Cancer Incidence Trends in Successive Social Generations in the US. JAMA Netw Open. 2024 Jun 3;7(6):e2415731. doi: 10.1001/jamanetworkopen.2024.15731. PMID: 38857048; PMCID: PMC11165384. Smeltzer MP, Wynes MW, Lantuejoul S, et al. The International Association for the Study of Lung Cancer Global Survey on Molecular Testing in Lung Cancer. J Thorac Oncol. 2020 Sep;15(9):1434-1448. doi: 10.1016/j.jtho.2020.05.002.The views and opinions expressed by the guest featured on this podcast are their own and do not necessarily reflect the official policy or position of Prime Therapeutics LLC, its hosts, or its affiliates. The guest's appearance on this podcast does not imply an endorsement of their views, products, or services by Prime Therapeutics LLC. All content provided is for informational purposes only and should not be construed as professional advice.

Esta semana hablaremos se sexo a lo bruto, sin pelos en la lengua, o incluso con pelos en la lengua. Vamos a hablar de sexo en plan salvaje (a estas horas se puede). Ricardo Moure es Biólogo Molecular y Doctor en Biotecnología Biomédica y ha escrito SEXO SALVAJE. EL KAMASUTRA DE LA NATURALEZA. Vaya, cosas de animalitos: hormigas, monos, ornitorrincos... Javier Armentia nos lleva de VIAJE AL CENTRO DE LA TIERRA y Pep Bruno nos cuenta EL BUQUE DE LOS TRES HACHAZOS. Sergio Martín nos cuenta las cosas que han pasado esta semana (la muerte del Papa, claro) y Sergio Fernández nos hace unas EMPANADILLAS RELLENAS CON CREMA DE QUESO PARMESANO, ALBAHACA Y CEBOLLA POCHADA (cuanto nombre para una empanadilla). En este programa somos así (asina se dice en mi pueblo)Escuchar audio

Learn more about Brodie's Research Database & AI Assistant

Big news! An American biotech company announced this week that they have brought the dire wolf back from extinction! We've honoured this great achievement by watching the prophetic film Dire Wolf (2009), a gory werewolf movie in which an American biotech company brought back the dire wolf from extinction... to create a military bioweapon! We've got our eyes on you, Colossal Biosciences... Watch Dire Wolf (2009) on Tubi: https://tubitv.com/movies/641656/dire-wolf The Dire Wolf (Aenocyon dirus): https://tarpits.org/stories/our-evolving-understanding-dire-wolves Bone Clones Dire Wolf Skull: https://boneclones.com/product/dire-wolf-skull-tarpit-finish-BC-020T Colossal Biosciences: https://colossal.com/ Colossal's Dire Wolf preprint on BioRxiv: https://www.biorxiv.org/content/10.1101/2025.04.09.647074v1.abstract Perri et al. (2021) Dire wolves were the last of an ancient New World canid lineage: https://doi.org/10.1038/s41586-020-03082-x Janczewski et al. (1992) Molecular phylogenetic inference from saber-toothed cat fossils of Rancho La Brea: https://doi.org/10.1073/pnas.89.20.9769 Hank Green – They Didn't Make Dire Wolves, They Made Something...Else: https://www.youtube.com/watch?v=Ar0zgedLyTw Beth Shapiro (2020) How to Clone a Mammoth: https://press.princeton.edu/books/paperback/9780691209005/how-to-clone-a-mammoth

Request Access to the FREE Health Impact SoftwareClick this link. ⁠⁠⁠FREE Health Impact APP⁠⁠⁠No strings attached—we will send an email, and you'll receive an exclusive download link.Take Action:

El doctor Elmer Huerta, asesor médico de RPP, comenta un estudio que afirma que las personas que viven en zonas con más días calurosos envejecen más rápido. ¿A qué se debe esto?

Gary Falcetano, Scientific Affairs Manager for Allergy at Thermo Fisher Scientific, is a leader in allergy and autoimmune diagnostics, providing specific IgE tests and the instruments to run them. Accurately diagnosing allergies can be challenging, but specific IgE testing can help confirm the underlying causes by looking at individual allergen components for precise diagnosis. This is the first step in determining the appropriate management approach to potentially interrupt the atopic march, where allergies can progress or even be life-threatening. Gary explains, "It runs the gamut of just about anything that could potentially be an allergy disease. So I think the majority of our testing is done in both environmental allergies and food allergies. What people think about when we, especially this time of year in the US, with spring about to become a big onslaught, are environmental allergies, including pollens, grass, trees, and weeds. Also, looking at some of the indoor triggers to environmental allergies like dust mites, pets, molds, and mice is pretty key when assessing for respiratory-type symptoms. On the food side, any of a number of foods can potentially cause a patient to produce specific IgE, which is the sensitization that allows us to become allergic." "We all think of respiratory allergies as straightforward, but there's an overlap of symptoms, especially from non-allergic causes, that can cause similar symptoms. So when thinking about respiratory allergies, we think about nasal congestion, post-nasal drip, and cough. Those symptoms can all be certainly caused by allergies, but they also can be caused by non-allergic triggers. That's one of the places where diagnostic allergy testing or specific IgE testing comes in to confirm whether we're dealing with an allergy. Then, if it's an allergy, what specifically is driving the symptoms? Once we rule out allergy, we can go down a whole other diagnostic pathway for all the various causes, like non-allergic rhinitis." #ThermoFisherScientific #Allergies #AllergyTesting #ClinicalDiagnostics #PatientCare #IgETesting thermofisher.com Listen to the podcast here

Gary Falcetano, Scientific Affairs Manager for Allergy at Thermo Fisher Scientific, is a leader in allergy and autoimmune diagnostics, providing specific IgE tests and the instruments to run them. Accurately diagnosing allergies can be challenging, but specific IgE testing can help confirm the underlying causes by looking at individual allergen components for precise diagnosis. This is the first step in determining the appropriate management approach to potentially interrupt the atopic march, where allergies can progress or even be life-threatening. Gary explains, "It runs the gamut of just about anything that could potentially be an allergy disease. So I think the majority of our testing is done in both environmental allergies and food allergies. What people think about when we, especially this time of year in the US, with spring about to become a big onslaught, are environmental allergies, including pollens, grass, trees, and weeds. Also, looking at some of the indoor triggers to environmental allergies like dust mites, pets, molds, and mice is pretty key when assessing for respiratory-type symptoms. On the food side, any of a number of foods can potentially cause a patient to produce specific IgE, which is the sensitization that allows us to become allergic." "We all think of respiratory allergies as straightforward, but there's an overlap of symptoms, especially from non-allergic causes, that can cause similar symptoms. So when thinking about respiratory allergies, we think about nasal congestion, post-nasal drip, and cough. Those symptoms can all be certainly caused by allergies, but they also can be caused by non-allergic triggers. That's one of the places where diagnostic allergy testing or specific IgE testing comes in to confirm whether we're dealing with an allergy. Then, if it's an allergy, what specifically is driving the symptoms? Once we rule out allergy, we can go down a whole other diagnostic pathway for all the various causes, like non-allergic rhinitis." #ThermoFisherScientific #Allergies #AllergyTesting #ClinicalDiagnostics #PatientCare #IgETesting thermofisher.com Download the transcript here

Molecular delivers an incredible Overview:LIVE alongside Visionobi from Attic Bar in Bristol. Buy 'Molecular - Fair Warning EP': https://overview.fanlink.tv/OVR107-Molecular Molecular https://facebook.com/moleculardnb https://instagram.com/rafmolecular https://soundcloud.com/moleculardnb Overview Music https://overviewmusic.co.uk https://patreon.com/overview https://facebook.com/overviewuk https://instagram.com/overviewuk https://soundcloud.com/overviewuk

Las plantas también sufren, de eso ya hablamos en uno de nuestros programas. Y, entre las cosas que más sufren está el cambio climático. Que los niveles de dióxido de carbono suban no es una buena noticia, ni siquiera para ellas. Porque, a pesar de utilizarlo en la fotosíntesis, con las altas temperaturas no es tan sencillo captarlo porque entran en un juego donde el riesgo es deshidratarse. Para hablar de ello tenemos con nosotros a Pedro Luis Rodríguez Egea, que es Profesor de Investigación afiliado al Instituto de Biología Molecular y Celular de Plantas del CSIC. Su investigación se centra principalmente en el esclarecimiento de los mecanismos moleculares que subyacen a la acción de las fitohormonas. Con experiencia en Biología Molecular y Genética, su trabajo contribuye significativamente a la comprensión del crecimiento vegetal, las respuestas al estrés y las vías bioquímicas relacionadas con la biosíntesis de coenzimas.

Buy: https://overview.fanlink.tv/OVR107-Molecular Portuguese producer and man on a mission, Molecular, makes his full debut on Overview Music with the hard and heavy 'Fair Warning' EP. A name that by now should need no introduction, Molecular has quickly become one of the standout rising talents in the world of Drum & Bass. His no-nonsense approach to blending the technical and raw aspects of production has earned him support from all corners of the scene. Molecular https://www.instagram.com/rafmolecular https://www.facebook.com/moleculardnb https://soundcloud.com/moleculardnb Overview Music https://patreon.com/overview https://facebook.com/overviewuk https://instagram.com/overviewuk https://soundcloud.com/overviewuk

Buy: https://overview.fanlink.tv/OVR107-Molecular Portuguese producer and man on a mission, Molecular, makes his full debut on Overview Music with the hard and heavy 'Fair Warning' EP. A name that by now should need no introduction, Molecular has quickly become one of the standout rising talents in the world of Drum & Bass. His no-nonsense approach to blending the technical and raw aspects of production has earned him support from all corners of the scene. Molecular https://www.instagram.com/rafmolecular https://www.facebook.com/moleculardnb https://soundcloud.com/moleculardnb Overview Music https://patreon.com/overview https://facebook.com/overviewuk https://instagram.com/overviewuk https://soundcloud.com/overviewuk

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: The future of healthcare lies in shifting from reactive treatment to predictive prevention, and our next guest is leading this transformation. Jim Kean, CEO of Molecular You, is harnessing molecular medicine and AI to identify health risks before they progress to disease. With an impressive track record as a serial healthcare entrepreneur, Jim pioneered online health communities with Sapient Health Network (later WebMD), revolutionized direct-to-consumer diagnostics with WellnessFX, and now leads Molecular You in expanding access to precision health insights. Join us to discover how Jim's unique perspective from seven startups and time in the healthcare insurance industry is helping navigate the complex healthcare landscape while driving innovation that can save both money and lives. Let's go!Episode Highlights:Technology detected early-stage pancreatic cancer through molecular pattern changes years before symptoms appearedPlatform analyzes 280+ biomarkers from a single blood sample with plans to expand to 825 markersAI identifies "risk signatures" for conditions like Alzheimer's with 95% accuracyCan determine different biological pathways leading to the same disease, enabling personalized treatments25% of all healthcare expenses will come from just 3% of people who will develop severe disease but aren't yet identifiedAbout our Guest: Jim Kean, CEO of Molecular You, is a technology executive known for driving innovation in consumer health and wellness platforms. At Molecular You, Jim is focused on expanding access to precision health insights that empower proactive healthcare decisions.Before joining Molecular You, Jim was General Manager of the Consumer Platform for Cambia Health, a Blue Cross Blue Shield insurer based in Portland, Oregon, where he drove the development of a next-generation platform for omni-channel consumer engagement. Later, he became General Manager of Value Management, focusing on population health analytics. As Founder and former CEO of WellnessFx™, Jim led the company to become a leader in direct-to-consumer health diagnostics; after founding the company In 2010, he sold it to Thorne (THRN) in 2013 for $25m.In 1995, Jim founded Sapient Health Network (SHN), pioneering online consumer health communities. SHN merged with WebMD in 1999, forming the platform that now attracts over 23 million monthly visitors. He successfully exited the company, turning a $5m investment into $187m in 3.5 years.Former Board Member of Portland Center Stage (PCS) – a highly regarded regional theatre. During his tenure as Treasurer and Chair of the Finance Committee, PCS achieved recognition for developing and opening the first Platinum LEED performing arts building. An avid outdoorsman, in 1999, he hiked the Pacific Crest Trail from Mexico to Canada. He graduated in 1984 from Lewis & Clark College in Portland, OR, and earned an MBA from Tuck School at Dartmouth in 1991. He enjoys the great outdoors and winter sports with his wife and three children. Links Supporting This Episode: Molecular You Website: CLICK HEREJim Kean LinkedIn page: CLICK HEREMolecular You LinkedIn:

Callum and Alyssa are joined by Professor Malcolm Richardson to talk about all things fungal diagnostics.In this, part 1 of 2 on diagnostics we discuss the use of biomarkers such as beta-D-Glucan and galactomannan, as well as serology and molecular techniques.Notes for this episode can be found: here.Send us a textSupport the showQuestions, comments, suggestions to idiotspodcasting@gmail.com or on Bluesky @idiots-pod.bsky.socialPrep notes for completed episodes can be found here (Not all episodes have prep notes).If you are enjoying the podcast please leave a review on your preferred podcast app!Feel like giving back? Donations of caffeine gratefully received!https://www.buymeacoffee.com/idiotspod

Britt Gillette discusses his work researching globalism and global empire in light of biblical prophecy. Cracks in the American Empire are beginning to emerge as its military might is waning and its dollar world reserve status is in danger. The tech revolution (e.g. AI, drone warfare) is making legacy systems obsolete and Britt fears that whoever achieves first-mover advantage will take over the entire planet. Molecular manufacturing will bring Skynet online, so to speak. He comments on the digital gulag, the mark of the beast, global depression, transhumanism which he believes will become the dominant philosophy, and more. Watch on BitChute / Brighteon / Rumble / Substack / YouTube Geopolitics & Empire · Britt Gillette: Globalism & World Empire in Light of Bible Prophecy #538 *Support Geopolitics & Empire! Become a Member https://geopoliticsandempire.substack.com Donate https://geopoliticsandempire.com/donations Consult https://geopoliticsandempire.com/consultation **Visit Our Affiliates & Sponsors! Above Phone https://abovephone.com/?above=geopolitics easyDNS (15% off with GEOPOLITICS) https://easydns.com Escape Technocracy course (15% off with GEOPOLITICS) https://escapethetechnocracy.com/geopolitics PassVult https://passvult.com Sociatates Civis (CitizenHR, CitizenIT, CitizenPL) https://societates-civis.com Wise Wolf Gold https://www.wolfpack.gold/?ref=geopolitics Websites Substack https://brittgillette.substack.com Books https://www.amazon.com/stores/Britt-Gillette/author/B00JROW75G About Britt Gillette Britt Gillette's books include Christian apologetics, Christian inspirational, and Christian non-fiction books with a specific emphasis on bible prophecy. His writing ministry is focused on proclaiming two messages: "the Messiah is Jesus" (Acts 5:42) and "Jesus is coming soon!" (Revelation 22:20). Britt is a devoted follower of Jesus Christ, husband to Jen, and father to Samantha, Tommy, and Elizabeth. He and his family live in southeastern Virginia. Britt is the founder of End Times Bible Prophecy (www.end-times-bible-prophecy), a website dedicated to helping people learn more about the amazing prophecies found in the Bible. His bible prophecy commentary appears on numerous websites. Britt is author of the Christian books "Coming To Jesus: One Man's Search for Truth and Life Purpose," "Signs Of The Second Coming: 11 Reasons Jesus Will Return in Our Lifetime," "Racing Toward Armageddon: Why Advanced Technology Signals the End Times," and "The End Times: A Guide to Bible Prophecy and the Last Days." *Podcast intro music is from the song "The Queens Jig" by "Musicke & Mirth" from their album "Music for Two Lyra Viols": http://musicke-mirth.de/en/recordings.html (available on iTunes or Amazon)

Guest: Lisa Baik, Postdoctoral researcher with the Department of Molecular, Cellular and Developmental Biology at Yale University

María Victoria Fonseca González es catedrática de Física Atómica Molecular y Nuclear y también profesora honorífica de la Universidad complutense, pero en cierto momento de su vida se dio cuenta que tenía ciertas preguntas cuya respuesta no hallaba en la ciencia.  Preguntas como ¿Qué somos realmente los humanos? ¿Cómo podemos gestionar nuestras emociones? ¿Cómo ser conscientes de las situaciones que vivimos y aprender a observar lo que sentimos? Como dice María Victoria: "Hay que empezar a entenderse de otra manera"

Request Access to the FREE Health Impact SoftwareClick this link. ⁠FREE Health Impact APP⁠No strings attached—we will send an email, and you'll receive an exclusive download link.Take Action:

Dr. Jonathan Usuka, CEO of Sapient, uses insights about proteomics and metabolomics to provide deep molecular characterization of diseases from a single sample to support drug discovery, development, and approval. The company's unique dataset combines real-world data with longitudinal molecular profiling of tens of thousands of samples across different diseases, ethnicities, genders, and ages.  By measuring proteins and metabolites, this data and insights engine helps pharmaceutical companies gain a significantly more comprehensive view of the molecular basis of disease, better understand drug targets, and predict potential drug outcomes and safety. Jonathan explains, "We support drug discovery and drug development, and a couple of things are going on in the industry right now in discovery and development. One is the overall pharma landscape of how a drug gets approved. That's been fairly static since the 1970s with the creation of the FDA. So clinical trials are well established, but the structure of it was based around not knowing much about the underlying drug target that your drug is interacting with. Since then, they've tightened up the requirements around mechanisms of action, but mostly, the process itself is almost protein agnostic in terms of the development process and how the drug interacts with patients." "So what we do, what has happened recently, is a revolution in understanding the molecular basis of disease and how the therapeutics interact with it at a molecular level. We support pharmaceutical companies in understanding the safety and the efficacy and being able to predict how their therapies will do in the clinic, and then really understanding a lot more about the available drug targets, which expands the arsenal of ways to fight disease."    "At Sapient, we don't just identify dynamic biomarkers, biomarkers that change with disease or change in response to therapy. We also give a lot of context about those biomarkers. We also say where we have seen those biomarkers occur and how they have changed in response to other therapies, disease conditions, and immunological responses. So, a pharma company can see better what it's getting into when it invests in a dynamic biomarker."  #SapientBio #Multiomics #Proteomics #Metabotomics #DarkProteome #BeyondtheGenome #Plasmaproteomics #Biomarkers  sapient.bio Listen to the podcast here

Dr. Jonathan Usuka, CEO of Sapient, uses insights about proteomics and metabolomics to provide deep molecular characterization of diseases from a single sample to support drug discovery, development, and approval. The company's unique dataset combines real-world data with longitudinal molecular profiling of tens of thousands of samples across different diseases, ethnicities, genders, and ages.  By measuring proteins and metabolites, this data and insights engine helps pharmaceutical companies gain a significantly more comprehensive view of the molecular basis of disease, better understand drug targets, and predict potential drug outcomes and safety. Jonathan explains, "We support drug discovery and drug development, and a couple of things are going on in the industry right now in discovery and development. One is the overall pharma landscape of how a drug gets approved. That's been fairly static since the 1970s with the creation of the FDA. So clinical trials are well established, but the structure of it was based around not knowing much about the underlying drug target that your drug is interacting with. Since then, they've tightened up the requirements around mechanisms of action, but mostly, the process itself is almost protein agnostic in terms of the development process and how the drug interacts with patients." "So what we do, what has happened recently, is a revolution in understanding the molecular basis of disease and how the therapeutics interact with it at a molecular level. We support pharmaceutical companies in understanding the safety and the efficacy and being able to predict how their therapies will do in the clinic, and then really understanding a lot more about the available drug targets, which expands the arsenal of ways to fight disease."    "At Sapient, we don't just identify dynamic biomarkers, biomarkers that change with disease or change in response to therapy. We also give a lot of context about those biomarkers. We also say where we have seen those biomarkers occur and how they have changed in response to other therapies, disease conditions, and immunological responses. So, a pharma company can see better what it's getting into when it invests in a dynamic biomarker."  #SapientBio #Multiomics #Proteomics #Metabotomics #DarkProteome #BeyondtheGenome #Plasmaproteomics #Biomarkers  sapient.bio Download the transcript here

Could the next nanotechnology breakthrough come from a college student's laptop rather than a million-dollar lab?In this Ecosystemic Futures episode, Marco Annunziata speaks with Dr. Aaron Santos, physicist and president of DNP123 Company. Santos examines nanotechnology as complex molecular networks rather than isolated components.Santos explains why physics fundamentally changes at nanoscale, requiring new paradigms. Despite predictions in the 1990s of a trillion-dollar nanotechnology industry by 2015, the field evolved differently—with mRNA vaccines and semiconductor advances representing "hidden successes" that power other technologies without the nanotech label.The conversation details how cloud laboratories and AI tools are breaking the million-dollar equipment barrier, thereby creating a research ecosystem that was previously impossible. Santos argues that nanotechnology exemplifies emergent properties in complex systems, where the collective behavior of simple molecules creates sophisticated functions—a model future nanotechnology will follow rather than the "smart nanobots" of science fiction. This extends to broader implications for society, economics, and consciousness in a world where atomic-scale manipulation reshapes our understanding of scarcity. Highlights:Scale Physics: Surface area (L²) vs. volume (L³) scaling transforms force dominance at nanoscaleEmergent Properties: Complex protein networks outperform theoretical discrete nanobotsResearch Infrastructure: Cloud labs democratize physical experimentation Network Theory Applications: Mathematical frameworks apply across nanoscale and macroscale systems Research-to-Market Gap: Critical funding void between academic research and commercial products Santos demonstrates why network approaches now replace reductionist models across scientific domains.Guest: Dr. Aaron Santos, physicist and president of DNP123 CompanyHost: Marco Annunziata, Co-Founder, Annunziata + Desai PartnersSeries Hosts: Vikram Shyam, Lead Futurist, NASA Glenn Research CenterDyan Finkhousen, Founder & CEO, Shoshin Works

Run it Red episode 120 is here with Lidvall, D'Julz, Truncate, Planetary Assault Systems, Surgeon, Ecilo, Satoshi Tomiie and loads more coming correct with new sounds in this one. As always, full tracklist is below - go and check out the artists/labels and show some love

In today's episode of the podcast, Alec sits down with Dr. Nestor Rodriguez, rekindling a friendship that start back when Alec was a student at the University of Wisconsin-Madison. At that time, Alec was curious about business and entrepreneurship and reached out to Nestor for advice. He said absolutely and offered Alec insights into not only his journey in business, but the life of an entrepreneur in general. The two discuss servant leadership, giving back, and innovation. How do you seize opportunities to elevate yourself? Dive in to find in - Welcome back to the Forged Ingold Podcast!If you like the show please subscribe and leave a 5 star rating - that and texting it to a friend are the easiest ways you can help us grow. Follow the podcast on Instagram: @ForgedIngold and email the show at forgedingoldpodcast@gmail.comAlec Ingold is an author, speaker, philanthropist, and professional football player. Learn more at alecingold.comAdditional notes about today's guest:Dr. Nestor Rodriguez is a board-certified Emergency Medicine physician, MedicalDirector, and founder of Carbon World Health, where he is redefining healthoptimization by integrating medicine, fitness, and regenerative wellness. With a passionfor longevity and human performance, Dr. Rodriguez has worked with elite athletes,entrepreneurs, and high performers to help them maximize their health, energy, andvitality—not just for today, but for the long run.Dr. Rodriguez's journey is one of resilience, leadership, and innovation. After emigratingfrom El Salvador to South Central Los Angeles, he overcame language andsocioeconomic barriers to become the first in his family to earn a high school diploma,an Ivy League degree from Yale University in Molecular, Cellular, and DevelopmentalBiology, and a doctorate in medicine from the University of Wisconsin School ofMedicine and Public Health.During his medical training, Dr. Rodriguez was a trailblazer, serving as a Chief Residentin the inaugural class of the University of Wisconsin Emergency Medicine ResidencyProgram. His exceptional leadership and commitment to medical education led him tobecome an Assistant Residency Director, where he played a pivotal role in training thenext generation of emergency physicians. His dedication to teaching earned himnational recognition, being nominated for Assistant Residency Director of the Year andlater receiving the Faculty Teaching Award from the Council of Emergency MedicineResidency Directors.After a successful career in academic medicine, Dr. Rodriguez transitioned into privatepractice, where he now serves as the Medical Director of Emergency Services atWatertown Regional Medical Center. Beyond his clinical leadership, he has made asignificant impact as an entrepreneur and mentor, co-founding Carbon World Healthalongside his wife, Ashley Rodriguez, to create a comprehensive, science-drivenapproach to health, performance, and aesthetics.Dr. Rodriguez has been recognized with numerous awards, including the Impact Awardfrom the Urban League of Greater Madison, Entrepreneur of the Year by the LatinoChamber of Commerce of Dane County, and most recently, his company was a finalistfor the InBusiness Small Business of the Year Award (2024).At Mastermind and Annual Events, Dr. Rodriguez will bring his unique insights on high-performance health strategies, longevity optimization, and the power of investing in yourfuture self. Through cutting-edge medical advancements, fitness science, and mindsetshifts, he helps individuals bridge the gap between traditional healthcare and next-levelperformance.For those ready to take their health seriously, Dr. Rodriguez also offers virtual conciergemedical consults, bringing elite wellness strategies directly to clients worldwide.

Aimar Bretos entrevista a Rosa Porcel, doctora en Bioquímica y Biología Molecular y autora del libro 'Plantas que nos ayudan'

With money pouring in and an unprecedented level of public attention and excitement, scientists are publishing a steady stream of papers on ways to measure how rapidly a person's body is declining.However, there are mixed feelings of enthusiasm and apprehension among researchers about efforts to develop tests that measure the impact of ageing on the body, as they are often interpreted and presented without a full reckoning of the uncertainties that plague them.This is an audio version of our Feature: How quickly are you ageing? What molecular ‘clocks' can tell you about your health Hosted on Acast. See acast.com/privacy for more information.

In today's episode, OncLive teamed up with CURE to present a discussion with David A. Braun, MD, PhD, about his research on determinants of response to immune checkpoint inhibition (ICI) in patients with renal cell carcinoma (RCC). Dr Braun is an assistant professor of medicine (medical oncology), the Louis Goodman and Alfred Gilman Yale Scholar, and a member of the Center of Molecular and Cellular Oncology at Yale Cancer Center in New Haven, Connecticut. In this exclusive interview, Dr Braun discussed the rationale for investigating molecular factors that contribute to exceptional ICI responses among patients with RCC, as well as the key findings from this study. He also shared how these findings may affect cancer care and influence shared decision-making strategies for patients receiving immunotherapy.

SpaceTime Series 28 Episode 36The Astronomy, Space and Science News PodcastSpace Tornadoes Discovered in the Milky Way's Core, SpaceX's Starship to Undertake a Mission to Mars Next Year, and Stranded Astronauts Finally Return Home After Nine Months in SpaceIn this episode of SpaceTime, we explore the astonishing discovery of enormous space tornadoes swirling in the Milky Way's central core. Astronomers have unveiled these spectacular formations, detected using the Atacama Large Millimeter/submillimeter Array (ALMA), which reveal the dynamic processes surrounding the supermassive black hole Sagittarius A*. We discuss the implications of this find for our understanding of the galaxy's central molecular zone and the mechanisms driving material circulation within it.SpaceX's Ambitious Mars MissionWe also cover SpaceX's plans for its Starship rocket, which is set to undertake its first mission to Mars next year. Elon Musk outlines the ambitious timeline for human colonization of the red planet, with unmanned missions paving the way for human exploration as early as 2029. We delve into the current status of the Starship program and its significance for future lunar and Martian endeavors.Return of Stranded AstronautsAdditionally, we celebrate the safe return of NASA astronauts who were stranded aboard the International Space Station for nine months due to delays with Boeing's Starliner spacecraft. The crew's return aboard a SpaceX Dragon capsule marks the end of a dramatic saga that began with Starliner's initial launch. We recount the challenges faced by the astronauts and the implications for future crewed missions.00:00 Space Time Series 28 Episode 36 for broadcast on 24 March 202500:49 Discovery of space tornadoes in the Milky Way06:30 Implications for the central molecular zone12:15 Overview of SpaceX's Mars mission plans18:00 Status of the Starship program and its future22:45 Return of stranded astronauts from the ISS27:00 Summary of recent space exploration developments30:15 Discussion on the impact of sleep patterns on mental healthwww.spacetimewithstuartgary.comwww.bitesz.com

NAD is all the rage. Its such a crucial molecule in our body that declines with age. You're probably not sure if you should be taking NAD or a precursor like NMN or NR, and if so, how – do we take supplements, IVs, injectables…? But you may have also heard of the dangerous pathways that some of these molecules take us down that increases the risk for cancer. So is there a better way? Yes! Molecular biologist Dr. Sandra Kaufmann, who is completely unbiased, clears the confusion and helps us navigate this world of NAD. It gets a little geeky, so break out your pen and paper, and keep the speed on 1x.  We cover: -   NAD basics -   What is NAD vs NAD+ vs NAD- minus -   Different categories of what NAD does -   How NAD controls circadian rhythms -   Is fatigue due to NAD or something else? -   Is it better to optimize our ovaries with NAD or HRT? -   If, how and when to take NAD, NMN, NR and which one is best? -   The best time to take NAD or its precursors -   When is the only time to do an NAD infusion -   What happens to our DNA when NAD is low -   How NAD can be made from scratch in the body -   The dangers of NAD and its precursors that may triggering more inflammation -   Can you test NAD levels? -   Best way to increase NAD levels naturally -   The cheapest way to increase NAD levels -   What Dr. Sandra does personally for her NAD Dr. Sandra Kaufmann started her career in the field of cellular biology. She got her Master's Degree from the University of Connecticut in Tropical Ecology and Plant Physiology. And then she turned to medicine, and got her medical Degree at the University of Maryland. And for the last nearly decade she has been the Chief of Pediatric Anesthesia at the Joe DiMaggio Children's Hospital in Florida. Everyone in the biohacking world knows Dr. Kaufmann and outside of this world she's been recognized as “Best in Medicine” by the American Health Council.   PAST EPISODES ⁠Brand New Supplement Solutions⁠ ⁠3 Brain Supplements To Keep Your Marbles Exosomes vs Stem Cells   Contact Dr. Sandra Kaufmann: Website: kaufmannprotocol.com Instagram kaufmannantiaging Facebook: Kaufmann Anti-Aging Institute Email: kaufmannaai@gmail.com Book 1: The Kaufmann Protocol: Why We Age and How To Stop It Book 2 : The Kaufmann Protocol – Aging Solutions   Give thanks to our sponsors: Qualia senolytics and brain supplements. 15% off with code ZORA here.  Try BEAM minerals at 20% off with code ZORA here.http://beamminerals.com/ZORA Get Primeadine spermidine by Oxford Healthspan. 15% discount with code ZORA ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠here⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Get Mitopure Urolithin A by Timeline. 10% discount with code ZORA at https://timeline.com/zora Get Magnesium Breakthrough by Bioptimizers. 10% discount with code HACKMYAGE at https://bioptimizers.com/hackmyageTry OneSkin skincare with code ZORA for 15% off https://shareasale.com/r.cfm?b=2685556&u=4476154&m=102446&urllink=&afftrack= Join ⁠⁠⁠Biohacking Menopause⁠⁠⁠ before April 1, 2025 to win OneSkin OS-01 peptide facial supplement and OS-01 eye cream! 15% off with code ZORA at OneSkin. Join the Hack My Age community on: Facebook Page: ⁠⁠⁠⁠⁠@⁠Hack My Age⁠     Facebook Group: ⁠⁠⁠⁠⁠⁠@⁠Biohacking Menopause⁠⁠⁠⁠⁠⁠ ⁠  Private Women's Only Support Group: https://hackmyage.com/biohacking-menopause-membership/ Instagram: ⁠⁠⁠⁠⁠@⁠HackMyAge⁠    Website: ⁠⁠⁠⁠⁠⁠HackMyAge.com⁠   

Interview with Timothy M. Pawlik, MD, PhD, MPH, MTS, MBA, author of Molecular Testing and Targeted Therapies in Hepatobiliary Cancers: A Review. Hosted by Amalia Cochran, MD. Related Content: Molecular Testing and Targeted Therapies in Hepatobiliary Cancers

Garrett Butler, MD, is a devoted family man and physician serving rural West Virginia as a husband, father, son, and friend. With a strong academic foundation, he earned undergraduate degrees in Physics from Johns Hopkins University and Molecular and Cell Biology from Towson University, followed by an MD and Family Medicine residency from West Virginia University School of Medicine. He's a busy healthcare professional, working as a hospitalist at Vandalia Health Davis Medical Center and Broaddus Hospital, while also caring for patients as an outpatient family physician at Broaddus Family Care. On top of that, he serves as the medical director of Mansfield Place Nursing Home, showcasing his commitment to his community. Please check out the Mansfield Place nursing home YouTube page Work With Us: Arétē by RAPID Health Optimization Links: Anders Varner on Instagram Doug Larson on Instagram Coach Travis Mash on Instagram

For a long time, microbes like the ones in Yellowstone's hot springs were studied in isolation. Molecular ecologist Devaki Bhaya says we should be studying them in community. Here's why.If you liked this episode, check out our episode on the last universal common ancestor in the tree of life. Plus, make sure you never miss a new episode by following us on whichever podcasting platform you're listening from. Or leave us a review! It really helps the show.This episode was produced by Hannah Chinn, edited by our showrunner, Rebecca Ramirez, and fact-checked by Tyler Jones. Jimmy Keeley was the audio engineer.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy